Author:
Vuk T.,Hećimović A.,Jukić I.,Ravlić S.,Kurtović T.,Rnjak D.,Halassy B.
Subject
Biochemistry (medical),Clinical Biochemistry,Hematology
Reference10 articles.
1. COVID-19 convalescent plasma therapy and immunodeficiency;Mungmunpuntipantip;Transfus Clin Biol,2021
2. AABB. Toolkit updated 04/14/21COVID-19 Convalescent Plasma (CCP) under emergency use authorization. Available at: https://www.aabb.org/docs/default-source/default-document-library/regulatory/toolkit-for-ccp-under-eua.pdf?sfvrsn=741be857_18.
3. Rnjak D, Ravlic S, Sola AM, Halassy B, Semnicki J, Superba M, et al. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? Transfus Clin Biol, https://doi.org/10.1016/j.tracli.2021.04.004.
4. Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19;Rodionov;Lancet Microbe,2021
5. Early safety indicators of COVID-19 convalescent plasma in 5000 patients;Joyner;J Clin Invest,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献